Clinical Trial Update: Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer [NA]

View source ↗

Summary

A clinical trial update examining a regimen of bevacizumab with doxorubicin and cyclophosphamide followed by nab-paclitaxel and continued bevacizumab in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Adriamycin (doxorubicin)
• Avastin (bevacizumab)
• Cytoxan (cyclophosphamide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | NA | Status: UNKNOWN